112 related articles for article (PubMed ID: 6330664)
21. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
Juszczak M; Boczek-Leszczyk E; Stempniak B
J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
[TBL] [Abstract][Full Text] [Related]
22. Arginine vasopressin enhances periaqueductal gray synthesis and secretion of enkephalin and endorphin in the rat.
Yang J; Yang Y; Xu HT; Chen JM; Liu WY; Lin BC
Brain Res Bull; 2006 Dec; 71(1-3):193-9. PubMed ID: 17113946
[TBL] [Abstract][Full Text] [Related]
23. Only arginine vasopressin, not oxytocin and endogenous opiate peptides, in hypothalamic paraventricular nucleus play a role in acupuncture analgesia in the rat.
Yang J; Liu WY; Song CY; Lin BC
Brain Res Bull; 2006 Feb; 68(6):453-8. PubMed ID: 16459202
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
Qadri F; Culman J; Veltmar A; Maas K; Rascher W; Unger T
J Pharmacol Exp Ther; 1993 Nov; 267(2):567-74. PubMed ID: 8246129
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of release of neurohypophysial hormones by endogenous opioid peptides in pregnant and parturient rats.
Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
Brain Res; 1986 Sep; 382(2):352-9. PubMed ID: 3756522
[TBL] [Abstract][Full Text] [Related]
26. Bifemelane hydrochloride reduces plasma beta-endorphin-like immunoreactivity levels in rats.
Mitsuma T; Hirooka Y; Yuasa K; Nogimori T
Exp Clin Endocrinol; 1990 Aug; 95(3):301-5. PubMed ID: 2245819
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of hypothalamic paraventricular nucleus to C- and N-terminal angiotensin fragments: vasopressin release and drinking.
Qadri F; Wolf A; Waldmann T; Rascher W; Unger T
J Neuroendocrinol; 1998 Apr; 10(4):275-81. PubMed ID: 9630397
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of the post-haemorrhagic vasopressin release from the posterior pituitary lobe.
Lipińska S; Traczyk WZ; Kokot F
Acta Physiol Pol; 1986; 37(3):109-17. PubMed ID: 3548218
[TBL] [Abstract][Full Text] [Related]
29. Ca2+ clearance mechanisms in neurohypophysial terminals of the rat.
Sasaki N; Dayanithi G; Shibuya I
Cell Calcium; 2005 Jan; 37(1):45-56. PubMed ID: 15541463
[TBL] [Abstract][Full Text] [Related]
30. Arginine8 vasopressin potentiates the beta-endorphin-releasing activity of ovine corticotropin-releasing factor (oCRF) in vitro.
Culler MD; Turkelson CM; Thomas CR; Arimura A
Proc Soc Exp Biol Med; 1983 Jun; 173(2):264-9. PubMed ID: 6306671
[TBL] [Abstract][Full Text] [Related]
31. Subchronic treatment with fragments of beta-endorphin prevents electroencephalographic seizures and behavioral alterations induced by centrally administered beta-endorphin in the rabbit.
Di Giannuario A; Pieretti S; Luzi M; Loizzo A
J Pharmacol Exp Ther; 1994 Feb; 268(2):1040-50. PubMed ID: 8113960
[TBL] [Abstract][Full Text] [Related]
32. Non-opiate beta-endorphin fragments and dopamine--II. beta-Endorphin 2-9 enhances apomorphine-induced stereotypy following subcutaneous and intra-striatal injection.
Van Ree JM
Neuropharmacology; 1982 Nov; 21(11):1103-9. PubMed ID: 6891031
[TBL] [Abstract][Full Text] [Related]
33. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats.
Ciosek J
J Physiol Pharmacol; 2002 Sep; 53(3):423-37. PubMed ID: 12369739
[TBL] [Abstract][Full Text] [Related]
34. Behavioral effects of non-opioid fragments of beta-endorphin.
van Ree JM; de Wied D
Prog Clin Biol Res; 1985; 192():277-84. PubMed ID: 2934744
[TBL] [Abstract][Full Text] [Related]
35. Effect of tamoxifen on pituitary vasopressin level.
Kundi SA; Forsling M; Kleimestur H; Wazir S; Khan TM
J Ayub Med Coll Abbottabad; 2004; 16(4):80-3. PubMed ID: 15762072
[TBL] [Abstract][Full Text] [Related]
36. Chronic osmotic stimuli increase salusin-beta-like immunoreactivity in the rat hypothalamo-neurohypophyseal system: possible involvement of salusin-beta on [Ca2+]i increase and neurohypophyseal hormone release from the axon terminals.
Saito T; Dayanithi G; Saito J; Onaka T; Urabe T; Watanabe TX; Hashimoto H; Yokoyama T; Fujihara H; Yokota A; Nishizawa S; Hirata Y; Ueta Y
J Neuroendocrinol; 2008 Feb; 20(2):207-19. PubMed ID: 18047553
[TBL] [Abstract][Full Text] [Related]
37. Neurohypophysial peptides. Histaminergic regulation and function in adenohypophysial secretion.
Kjaer A
Dan Med Bull; 1996 Dec; 43(5):391-406. PubMed ID: 8960813
[TBL] [Abstract][Full Text] [Related]
38. Effects of eel calcitonin on plasma beta-endorphin-like immunoreactivity levels in rats.
Mitsuma T; Hirooka Y; Nomura A; Okamoto H; Nogimori T
Endocrinol Exp; 1988 Jun; 22(2):107-12. PubMed ID: 2970383
[TBL] [Abstract][Full Text] [Related]
39. Des-tyr-gamma-endorphin (DT gamma E) and pineal levels of melatonin and arginine vasopressin (AVP).
King MG; Geffard MR; Chavreau J; Gaffori O; Le Moal M; Muyard JP
Eur J Pharmacol; 1981 Dec; 76(2-3):271-4. PubMed ID: 6120844
[TBL] [Abstract][Full Text] [Related]
40. In vitro release of hypothalamic beta-endorphin (beta E) by arginine vasopressin, corticotropin-releasing hormone and 5-hydroxytryptamine: evidence for release of opioid active and inactive beta E forms.
Bronstein DM; Akil H
Neuropeptides; 1990 May; 16(1):33-40. PubMed ID: 2250765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
